These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12399192)

  • 1. Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.
    Griffin KF; Eyles JE; Spiers ID; Alpar HO; Williamson ED
    Vaccine; 2002 Nov; 20(31-32):3650-7. PubMed ID: 12399192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE; Elvin SJ; Westwood A; Lebutt CS; Alpar HO; Somavarapu S; Williamson ED
    Vaccine; 2004 Oct; 22(31-32):4365-73. PubMed ID: 15474730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recombinant Attenuated
    Singh AK; Curtiss R; Sun W
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ; Williamson ED
    Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.
    Liu WT; Hsu HL; Liang CC; Chuang CC; Lin HC; Liu YT
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):58-69. PubMed ID: 17640293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single dose sub-unit vaccine protects against pneumonic plague.
    Williamson ED; Eley SM; Stagg AJ; Green M; Russell P; Titball RW
    Vaccine; 2000 Oct; 19(4-5):566-71. PubMed ID: 11027822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.
    Williamson ED; Vesey PM; Gillhespy KJ; Eley SM; Green M; Titball RW
    Clin Exp Immunol; 1999 Apr; 116(1):107-14. PubMed ID: 10209513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine.
    Wang D; Jia N; Li P; Xing L; Wang X
    Sci China C Life Sci; 2007 Oct; 50(5):600-4. PubMed ID: 17879056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
    Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T; Adamovicz JJ; Cyr SL; Bolt CR; Bellerose N; Pitt LM; Lowell GH; Burt DS
    Vaccine; 2006 Mar; 24(10):1625-32. PubMed ID: 16243411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
    Williamson ED; Packer PJ; Waters EL; Simpson AJ; Dyer D; Hartings J; Twenhafel N; Pitt ML
    Vaccine; 2011 Jun; 29(29-30):4771-7. PubMed ID: 21570437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
    Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.
    Williamson ED; Eley SM; Stagg AJ; Green M; Russell P; Titball RW
    Vaccine; 1997 Jul; 15(10):1079-84. PubMed ID: 9269050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits.
    Eyles JE; Williamson ED; Spiers ID; Stagg AJ; Jones SM; Alpar HO
    J Control Release; 2000 Jan; 63(1-2):191-200. PubMed ID: 10640592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines.
    Eyles JE; Spiers ID; Williamson ED; Alpar HO
    Vaccine; 1998 Dec; 16(20):2000-9. PubMed ID: 9796057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.